In France

Important (and not so important) announcements

  • New car registrations were up 10.75% in September, according to the PFA.
  • UAW drops unfair labor practice lawsuits against General Motors and Stellantis (I talk about it every day because there’s news, but this news is a bit sterile because it’s the consequence of tactical standoff between the union and the manufacturers).
  • In Australia, the setbacks of the Airbus NH90 continue.
  • Bernard Arnault’s lawyer believes that the LVMH boss’s transaction with the Russian Nikolai Sarkisov, which is the subject of an investigation in France, was carried out in compliance with the law.
  • Sodexo sells its home care division in Halifax.
  • TechnipFMC has been awarded an engineering, procurement, construction and installation contract from Equinor for its Rosebank project, west of the Shetland Islands in the United Kingdom.
  • Spie acquires 85% of Réseaux Environnement.
  • Forvia sells part of its commercial vehicle exhaust gas post-treatment activities in Europe and the United States to Cummins for €199.2 million.
  • Maurel met with the Gabonese authorities and is continuing his projects, including the acquisition of Assala.
  • Imerys considers that the sale of its assets dedicated to the paper market to Syntagma Capital was now highly improbable, without specifying the reasons, but assures that its current Ebitda objective for 2023 will not be affected by this announcement.
  • Bonduelle is targeting revenue growth of around 5% and an operating margin above 3% for the 2023/2024 financial year.
  • Casino has announced an extension to October 3 of the deadline to conclude a “lock-up” agreement with its creditors. Furthermore, Casino and Les Mousquetaires announce that they have completed the sale of the first wave of 61 points of sale and have extended their partnerships to purchasing and supplies.
  • La Française des Jeux has finalized the acquisition of ZEturf.
  • Biosynex will absorb Theradiag.
  • Abivax files for listing in the United States.
  • ProciseDx (Biosynex) obtains the first authorizations from the FDA for therapeutic monitoring tests for treatments such as Remicade, Humira and their biosimilars.
  • Planisware launches its IPO on Euronext Paris.
  • They have published / They must publish : Argan, Equasens, Dekuple, Geneuro, Buy-Rent, SFPI Group…

In the big world

Important (and not so important) announcements

  • The EU launches an anti-competition investigation into the artificial intelligence chip market dominated by Nvidia.
  • BAE Systems wins £4bn UK contract for AUKUS submarine programme.
  • UBS compromises to settle Crédit Suisse litigation linked to Mozambique. The Swiss bank also specifies that it “is not aware” of the American investigation into compliance failures with regard to sanctions against Russia.
  • Apple identifies iPhone 15 overheating issues.
  • BASF plans to sell around ten billion euros in assets.
  • Silver Lake and its partner obtain 87% of the shares of Software AG following the public purchase offer.
  • BaFin will send a special controller to Deutsche Bank because of problems at PostBank, according to Handelsblatt.
  • BP Plc announces the departure of its director of American operations, Dave Lawler, replaced by Orlando Alvarez.
  • Novartis has finalized the sale of its ophthalmology assets to Bausch + Lomb for up to $2.5 billion.
  • Ascential confirms exclusive discussions with Apax on a possible sale of WGSN.
  • Two groups, including Apollo, are acquiring the airline SAS AB, according to Aftenposten
  • Vestas wins an order for 76 MW in Italy.
  • Axel Springer has not officially launched a bid process for British newspapers Daily Telegraph and Sunday Telegraph, according to Reuters, after rumors to the contrary.
  • Uniper will repay €2 billion in state aid this week.
  • The main publications of the day: Aryzta, James Halstead…All the agenda here.